CLINICAL DEVELOPMENT PHASE 2 STUDY
$74,926,240
| Recipient | RESILIENCE GOVERNMENT SERVICES, INC. UEI GC2RFAZK8G64 |
|---|---|
| Award ID | W911SR22F0014 |
| Award amount | $74,926,240 |
| Award type | DELIVERY ORDER |
| Awarding agency | Department of Defense — Department of the Army |
| NAICS | 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| PSC | AN42 |
| Start date | Jan 4, 2022 |
| End date | Feb 29, 2028 |
| Place of performance | FREDERICK, MD |
| Record updated | Aug 1, 2022 |
View the official award record
More awards won by RESILIENCE GOVERNMENT SERVICES, INC.
MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY
Department of Defense · $282,290,978 · Mar 20, 2013
ACQUISITION OF FDA APPROVED PRODUCT
Department of Defense · $249,006,382 · Jan 3, 2022
DRUG SUBSTANCE (DS) PROCESS VALIDATION, DRUG PRODUCT (DP) PROCESS VALIDATION, CLINICAL DEVELOPMENT PHASE 3, AND STORAGE/STABILITY FOR THE PROGRAM WITH ULTIMATE GOAL OF U.S. F.D.A. LICENSURE OF BONT MAB G03-52-01 DRUG PRODUCT.
Department of Defense · $67,556,120 · Mar 7, 2023
DS PROCESS CHARACTERIZATION
Department of Defense · $10,308,533 · Jun 16, 2022
TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018
Department of Health and Human Services · $9,634,984 · Sep 9, 2019
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids